McNeil Products - Benylin Cold and Flu

The winter ailments market, valued at £377 million, has shown little or no growth over recent years. Within winter ailments, the cough share of the category is static, Benylin is the market leader within cough with 30% value share of cough medicines, but only 3.8% value share in cold and flu, with a presence limited to the Pharmacy only segment of the market.

McNeil Products – Benylin Cold and Flu

Packaging Branded Non FoodCreative Leap

EXECUTIVE SUMMARY

The winter ailments market, valued at £377 million, has shown little or no growth over recent years. Within winter ailments, the cough share of the category is static,

Benylin is the market leader within cough with 30% value share of cough medicines, but only 3.8 % value share in cold and flu, with a presence limited to the P (Pharmacy only) segment of the market.

An opportunity existed to launch a new Benylin branded Cold and Flu offering into the highly contested GSI category...

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands